BMJ子刊:穿对鞋就能预防足部溃疡?定制鞋履可提高糖尿病患者的短期和长期依从性!

2022-02-10 MedSci原创 MedSci原创

在临床实践中,可使用常规及室内定制的鞋履,以帮助病人坚持穿鞋。

糖尿病患者足部溃疡1年内复发率约为40%,3年内复发率为60%,给患者和护理人员带来沉重负担,适当的预防显得至关重要。定制鞋类是帮助预防足部溃疡的有效干预措施,并在国际指南中得到推荐。这种鞋通过重新分配机械应力并且提供适当的贴合度来降低溃疡风险。本研究旨在探讨存在足底溃疡高风险的糖尿病患者中,提供定制室内鞋以及在拥有常规定制鞋后,患者穿鞋依从性的变化。

在基线检查时(常规定制鞋)以及在提供定制室内鞋(室内鞋和常规鞋)后1个月和12个月,研究者通过穿着定制鞋的步骤百分比客观评估患者室内和室外的依从性。主要组:基线室内依从性较低(<80%)的参与者;第二组:基线室内依从性高(80%)的参与者。比较了室内鞋和常规定制鞋的足底压力峰值。在3个月时通过问卷调查评估鞋子的可用性。在12个月时,通过参与者/处方报告评估溃疡复发。

调查研究显示,在31名参与者中,23人的室内依从性较低 (<80%)。该组的总体依从性从基线时的中位数65%增加到1个月时的77% (60%–89%)和12个月时的87%(60%–93%)。这是由于室内依从性显着增加:基线:48%(21%–63%);1个月:71%(50%–83%);和12个月:77%(40%–91%)。室内鞋和常规定制鞋的平均峰值足底压力相当。参与者对可用性持积极态度。一年溃疡复发率为26%。

穿着规定鞋履、在室内穿鞋时间和普通鞋履在一天内的小时数中所采取的步骤百分比,以及穿室内鞋履相对于总穿鞋时间的百分比

室内和常规定制鞋的足底压力峰值

总而言之,在为糖尿病足部溃疡的高危人群提供了定制的室内鞋后,他们的鞋类依从性在短期和长期内都有所增加,因为他们在室内积极地穿着新提供的室内鞋。在临床实践中,可使用常规及室内定制的鞋履,以帮助病人坚持穿鞋。

参考文献:Keukenkamp R, van Netten JJ, Busch-Westbroek TE, et al Custom-made footwear designed for indoor use increases short-term and long-term adherence in people with diabetes at high ulcer risk BMJ Open Diabetes Research and Care 2022;10:e002593. doi: 10.1136/bmjdrc-2021-002593

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849366, encodeId=a685184936604, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Dec 13 16:14:37 CST 2022, time=2022-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191948, encodeId=f0ed119194825, content=新方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:28:11 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319362, encodeId=392013193627c, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475221, encodeId=e24714e52217a, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-12-13 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849366, encodeId=a685184936604, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Dec 13 16:14:37 CST 2022, time=2022-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191948, encodeId=f0ed119194825, content=新方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:28:11 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319362, encodeId=392013193627c, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475221, encodeId=e24714e52217a, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 ms3000000637975859

    新方法

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1849366, encodeId=a685184936604, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Dec 13 16:14:37 CST 2022, time=2022-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191948, encodeId=f0ed119194825, content=新方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:28:11 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319362, encodeId=392013193627c, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475221, encodeId=e24714e52217a, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 fyxzlh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849366, encodeId=a685184936604, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Dec 13 16:14:37 CST 2022, time=2022-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191948, encodeId=f0ed119194825, content=新方法, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Thu Feb 10 18:28:11 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319362, encodeId=392013193627c, content=<a href='/topic/show?id=60172686668' target=_blank style='color:#2F92EE;'>#依从性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26866, encryptionId=60172686668, topicName=依从性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1475221, encodeId=e24714e52217a, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 10 13:14:37 CST 2022, time=2022-02-10, status=1, ipAttribution=)]

相关资讯

Diabetes Care:动脉僵硬、遗传风险与2型糖尿病

ASI与T2D风险升高之间呈剂量反应关联,而PP和T2D呈非线性J型关联。此外,ASI与T2D之间的关联因对T2D较高的遗传易感性而部分加强。

IJBNPA:健康的生活方式后,代谢组学和2型糖尿病在西班牙人群中的发病率。

糖尿病是一种流行病——2019年至少有4.63亿20-79岁的人罹患糖尿病,是导致残疾和死亡的主要原因。

Metabolism:肥胖和2型糖尿病住院患者的孟德尔随机化研究

2019冠状病毒病(COVID-19)大流行是由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染引起的。SARS- cov -2的毒性不像SARS,大量患者无症状或症状较轻

Diabetes Care:白细胞端粒长度缩短与2型糖尿病患者血糖进展相关

较短的rLTL与2型糖尿病患者的血糖进展风险增加显著相关,且与已知的危险因素无关。端粒长度可能是2型糖尿病患者血糖进展有用的生物标志物。

DVDR:基础胰岛素治疗2型糖尿病患者快速血糖监测对糖化血红蛋白的影响

在全球范围内,HbA1c测量仍然是评估总体血糖控制水平的公认的金标准参数。

Diabetes:单核细胞miRNA与2型糖尿病的关系

大多数T2D相关miRNA也与HDL胆固醇浓度相关。这些miRNA靶向的基因属于胆固醇代谢转录组网络的关键节点。可导致单核细胞内胆固醇积累的miRNA表达处于高水平与T2D风险增加相关。